s-adenosylmethionine has been researched along with Depressive Disorder, Major in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.35) | 18.7374 |
1990's | 1 (2.17) | 18.2507 |
2000's | 11 (23.91) | 29.6817 |
2010's | 26 (56.52) | 24.3611 |
2020's | 6 (13.04) | 2.80 |
Authors | Studies |
---|---|
Ahmed, AT; Arnold, M; Bhattacharyya, S; Bobo, WV; Craighead, WE; Dunlop, BW; Frye, MA; Kaddurah-Daouk, R; Krishnan, R; Liu, D; Louie, G; MahmoudianDehkordi, S; McDonald, WM; Millington, DS; Moseley, MA; Neavin, D; Riva-Posse, P; Rush, AJ; Skime, MK; Thompson, JW; Wang, L; Weinshilboum, RM; Williams, LSJ | 1 |
Ahmed, AT; Arnold, M; Baillie, RA; Bhattacharyya, S; Craighead, WE; Dunlop, BW; Frye, MA; Han, X; John-Williams, LS; Kaddurah-Daouk, R; Krishnan, R; Louie, G; MahmoudianDehkordi, S; McDonald, W; Moseley, MA; Riva-Posse, P; Rush, AJ; Skime, MK; Thompson, JW; Weinshilboum, RM | 1 |
Ferrucci, L; Gould, TD; Kadriu, B; Khadeer, M; Lovett, J; Moaddel, R; Morris, PJ; Ravichandran, S; Shardell, M; Thomas, CJ; Yuan, P; Zarate, CA | 1 |
Baldi, A; Cioffi, V; Daglia, M; Di Minno, A; El-Seedi, HR; Esposito, C; Greco, A; Khalifa, SAM; Sacchi, R; Santonastaso, S; Sperandeo, R; Ullah, H | 1 |
Adams, L; Berk, M; Bousman, C; Byrne, GJ; Chamoli, S; Cribb, L; MacDonald, P; Menon, R; Mischoulon, D; Murphy, J; Nazareth, S; Ng, CH; Oliver, G; Sarris, J; Savage, K; Stough, C | 2 |
Bernard-Negron, R; Cusin, C; Dording, CM; Fava, M; I Papakostas, G; L Carpenter, L; Ludington, E; Mischoulon, D; Price, LH; R Tyrka, A; Sakurai, H; Yeung, AS | 1 |
Cameron, BR; Ferreira, L; MacDonald, ID; Targum, SD | 2 |
Adams, L; Berk, M; Bousman, C; Byrne, GJ; Chamoli, S; Cribb, L; MacDonald, P; Menon, R; Mischoulon, D; Murphy, J; Nazareth, S; Ng, C; Oliver, G; Sarris, J; Savage, K; Stough, C | 1 |
Wilson, A | 1 |
Anheyer, D; Cramer, H; Dobos, G; Haller, H | 1 |
Popper, CW | 1 |
Baer, L; Carpenter, LL; Clain, AJ; Dording, CM; Durham, K; Fava, M; Ludington, E; Mischoulon, D; Papakostas, GI; Price, LH; Tyrka, AR; Walker, R | 1 |
Fava, M; Mischoulon, D; Papakostas, GI; Sarris, J; Vitolo, O | 1 |
Admon, R; Bogdan, R; Dillon, DG; Dougherty, DD; Fava, M; Holmes, AJ; Iosifescu, DV; Kumar, P; Mischoulon, D; Nickerson, LD; Pizzagalli, DA | 1 |
Bottiglieri, T; Brown, RP; Gerbarg, PL; Muskin, PR | 1 |
Carpenter, LL; Fava, M; Mischoulon, D; Papakostas, GI; Price, LH; Tyrka, AR | 1 |
Carpenter, LL; Fava, M; Jaeger, A; Mischoulon, D; Ng, CH; Papakostas, GI; Price, LH; Sarris, J; Tyrka, AR | 1 |
Cavuto, M; de Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Girinelli, G; Iasevoli, F; Martinotti, G; Mazza, M; Orsolini, L; Perna, G; Piersanti, M; Serroni, N; Tomasetti, C; Valchera, A | 1 |
Freeman, MP | 1 |
Filteau, MJ; Kennedy, SH; Lam, RW; Lespérance, F; Parikh, SV; Patten, SB; Ravindran, AV | 1 |
Papakostas, GI | 1 |
Deligiannidis, KM; Freeman, MP | 1 |
Cohen, LS; Fava, M; Freeman, MP; Goodness, T; Mischoulon, D; Papakostas, GI; Tedeschini, E | 1 |
Alpert, JE; Fava, M; Mischoulon, D; Papakostas, GI; Shyu, I | 1 |
Nelson, JC | 1 |
Fleisch, SB; Ryan, ND; Travis, MJ | 1 |
Alpert, JE; Dording, CM; Mischoulon, D; Papakostas, GI; Shyu, I | 1 |
Alpert, JE; Brintz, CE; Levkovitz, Y; Mischoulon, D; Papakostas, GI | 2 |
Nahas, R; Sheikh, O | 1 |
Frisch, A; Gothelf, D; Green, T; Steingart, L; Weizman, A; Zarchi, O | 1 |
Alpert, JE; Arning, E; Bottiglieri, T; Fava, M; Mischoulon, D; Papakostas, GI | 1 |
Cassiello, CF; Iovieno, N; Papakostas, GI | 1 |
Delle Chiaie, R; Pancheri, P; Scapicchio, P | 1 |
Chiaie, RD; Pancheri, P; Scapicchio, P | 1 |
Ernst, J | 1 |
Cohen, BM; Damico, KE; Goren, J; Parow, AM; Renshaw, PF; Silveri, MM; Stoll, AL; Villafuerte, RA | 1 |
Alpert, JE; Fava, M; Papakostas, GI | 1 |
Bazzan, AJ; Schaller, JL; Thomas, J | 1 |
Alpert, JE; Bottiglieri, T; Burns, A; Fava, M; Mahal, Y; Mischoulon, D; Nierenberg, AA; Papakostas, G; Petersen, T; Worthington, JJ | 1 |
Cergnul, I; Jones, K; Karpiak, SE; Mendez, D; Shippy, RA | 1 |
Alpert, JE; Bottiglieri, T; Fava, M; Kolsky, AR; Magni, G; Moore, C; Moroz, G; Nierenberg, AA; Renshaw, P; Rosenbaum, JF; Spillmann, M | 1 |
Agnoli, A; Andreoli, V; Casacchia, M; Cerbo, R | 1 |
Agnoli, A; Andreoli, V; Casacchia, M; Cerbo, R; Fazio, C | 1 |
12 review(s) available for s-adenosylmethionine and Depressive Disorder, Major
Article | Year |
---|---|
S-Adenosyl Methionine (SAMe) for Depression in Adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Treatment Outcome; Young Adult | 2019 |
Complementary therapies for clinical depression: an overview of systematic reviews.
Topics: Acupuncture Therapy; Antidepressive Agents; Cognitive Behavioral Therapy; Complementary Therapies; Crocus; Curcumin; Dance Therapy; Depressive Disorder; Depressive Disorder, Major; Dietary Supplements; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Humans; Hypericum; Meta-Analysis as Topic; Mindfulness; Music Therapy; Phototherapy; Plant Preparations; Qigong; S-Adenosylmethionine; Systematic Reviews as Topic; Tai Ji; Trace Elements; Vitamins; Yoga; Zinc | 2019 |
Mood disorders in youth: exercise, light therapy, and pharmacologic complementary and integrative approaches.
Topics: 5-Hydroxytryptophan; Adolescent; Antidepressive Agents, Second-Generation; Carbidopa; Child; Complementary Therapies; Depressive Disorder, Major; Enzyme Inhibitors; Exercise Therapy; Humans; Hypericum; Integrative Medicine; Mood Disorders; Phototherapy; Phytotherapy; S-Adenosylmethionine; Treatment Outcome | 2013 |
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2016 |
Complementary and alternative medicine for perinatal depression.
Topics: Acupuncture Therapy; Complementary Therapies; Depression, Postpartum; Depressive Disorder, Major; Fatty Acids, Omega-3; Female; Herbal Medicine; Humans; Hypericum; Phototherapy; Phytotherapy; Plant Extracts; Pregnancy; Pregnancy Complications; S-Adenosylmethionine | 2009 |
Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Drug Therapy, Combination; Humans; S-Adenosylmethionine; Treatment Outcome | 2009 |
Complementary and alternative medicine for the treatment of depressive disorders in women.
Topics: Acupuncture Therapy; Adult; Complementary Therapies; Depressive Disorder; Depressive Disorder, Major; Exercise Therapy; Fatty Acids, Omega-3; Female; Humans; Hypericum; Phototherapy; Phytotherapy; Plant Preparations; S-Adenosylmethionine; Sex Factors; Treatment Outcome; United States | 2010 |
Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Topics: Adult; Antidepressive Agents; Complementary Therapies; Depressive Disorder, Major; Double-Blind Method; Fatty Acids, Omega-3; Female; Humans; Male; Placebos; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Sample Size; Severity of Illness Index; Treatment Outcome | 2010 |
Complementary and alternative medicine for the treatment of major depressive disorder.
Topics: Acupuncture Therapy; Complementary Therapies; Depressive Disorder, Major; Dietary Supplements; Exercise Therapy; Fatty Acids, Omega-3; Folic Acid; Humans; Hypericum; Phytotherapy; S-Adenosylmethionine | 2011 |
Folates and S-adenosylmethionine for major depressive disorder.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Humans; One-Carbon Group Transferases; Pteroylpolyglutamic Acids; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Tetrahydrofolates | 2012 |
Alternative treatment modalities in human immunodeficiency virus/acquired immune deficiency syndrome.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Complementary Therapies; Depressive Disorder, Major; HIV Infections; Humans; Peripheral Nervous System Diseases; S-Adenosylmethionine | 2003 |
S-adenosyl-methionine in depression: a comprehensive review of the literature.
Topics: Antidepressive Agents; Brain; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Treatment Outcome | 2003 |
25 trial(s) available for s-adenosylmethionine and Depressive Disorder, Major
Article | Year |
---|---|
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.
Topics: Adult; Amino Acids, Essential; Antidepressive Agents; Biogenic Amines; Carnitine; Cross-Over Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Glycerophospholipids; Humans; Ketamine; Lipids; Male; Metabolomics; Middle Aged; Sphingolipids; Young Adult | 2018 |
Efficacy of a food supplement based on S-adenosyl methionine and probiotic strains in subjects with subthreshold depression and mild-to-moderate depression: A monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial.
Topics: Depression; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Humans; Probiotics; Quality of Life; S-Adenosylmethionine | 2022 |
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial.
Topics: Adult; Antidepressive Agents; Australia; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; S-Adenosylmethionine; Treatment Outcome | 2020 |
Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; S-Adenosylmethionine; Treatment Outcome | 2020 |
Early score fluctuation and placebo response in a study of major depressive disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Humans; Outcome Assessment, Health Care; Placebo Effect; Psychiatric Status Rating Scales; Remission Induction; Reproducibility of Results; Research Design; S-Adenosylmethionine | 2020 |
Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Middle Aged; S-Adenosylmethionine; Treatment Failure | 2018 |
An augmentation study of MSI-195 (S-adenosylmethionine) in Major Depressive Disorder.
Topics: Adult; Antidepressive Agents; Body Mass Index; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; S-Adenosylmethionine; Severity of Illness Index | 2018 |
Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.
Topics: Adult; Aged; Antidepressive Agents; Australia; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Polymorphism, Genetic; S-Adenosylmethionine; Young Adult | 2019 |
A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2014 |
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.
Topics: Adult; Antidepressive Agents; Biomarkers; Carnitine; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Histamine; Humans; Male; Middle Aged; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties.
Topics: Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Citalopram; Corpus Striatum; Depressive Disorder, Major; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motivation; Psychiatric Status Rating Scales; Punishment; Regression Analysis; S-Adenosylmethionine; Treatment Outcome | 2015 |
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; S-Adenosylmethionine; Sex Characteristics | 2015 |
S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2010 |
SAMe and sexual functioning.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Libido; Male; Middle Aged; Penile Erection; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Treatment Outcome | 2012 |
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Self Report; Surveys and Questionnaires; Treatment Outcome | 2012 |
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder.
Topics: Adult; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors | 2012 |
The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Cross-Over Studies; Depressive Disorder, Major; DiGeorge Syndrome; Double-Blind Method; Feasibility Studies; Female; Humans; Male; Mental Disorders; Psychiatric Status Rating Scales; S-Adenosylmethionine; Young Adult | 2012 |
Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.
Topics: Biological Availability; Depressive Disorder, Major; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylhomocysteine; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Tetrahydrofolates | 2012 |
Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylmethionine; Safety; Treatment Outcome | 2002 |
A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Imipramine; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylmethionine | 2002 |
S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects.
Topics: Adenosine Triphosphate; Administration, Oral; Adult; Antidepressive Agents; Brain; Cerebrovascular Circulation; Depressive Disorder, Major; Drug Administration Schedule; Energy Metabolism; Female; Health Status; Humans; Magnetic Resonance Spectroscopy; Male; Models, Biological; Phosphocreatine; Phosphorus; Relaxation; S-Adenosylmethionine | 2003 |
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Depressive Disorder, Major; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; S-Adenosylmethionine; Severity of Illness Index; Treatment Outcome | 2004 |
Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms.
Topics: Adjustment Disorders; Adult; Aged; Anxiety; Attitude; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Drug Evaluation; Female; Humans; Hypochondriasis; Male; Middle Aged; Placebos; Psychomotor Disorders; Psychophysiologic Disorders; S-Adenosylmethionine; Suicide Prevention; Time Factors | 1976 |
[Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
Topics: Adjustment Disorders; Adrenal Glands; Adult; Aged; Animals; Bipolar Disorder; Brain; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Female; Humans; Liver; Lung; Male; Middle Aged; Myocardium; S-Adenosylmethionine | 1973 |
9 other study(ies) available for s-adenosylmethionine and Depressive Disorder, Major
Article | Year |
---|---|
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.
Topics: Carnitine; Depressive Disorder, Major; Humans; Phenotype; Retrospective Studies | 2020 |
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.
Topics: Amines; Antidepressive Agents; Carnitine; Citalopram; Depression; Depressive Disorder, Major; Humans; Lipids; Selective Serotonin Reuptake Inhibitors | 2021 |
Failed studies should not be used to malign good treatments.
Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors | 2014 |
Dr. Mischoulon and colleagues reply.
Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors | 2014 |
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.
Topics: Acupuncture Therapy; Adult; Antidepressive Agents; Complementary Therapies; Dehydroepiandrosterone; Depressive Disorder, Major; Dietary Supplements; Exercise Therapy; Fatty Acids, Omega-3; Herbal Medicine; Humans; Hypericum; Phototherapy; Phytotherapy; S-Adenosylmethionine; Sleep Deprivation; Tryptophan; Yoga | 2009 |
S-adenosyl methionine (SAMe) augmentation in major depressive disorder.
Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Costs; Drug Resistance; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Treatment Outcome | 2010 |
Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.
Topics: Antidepressive Agents; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; S-Adenosylmethionine; Treatment Outcome | 2010 |
SAMe use in children and adolescents.
Topics: Adolescent; Child; Depressive Disorder, Major; Female; Humans; Injections, Intramuscular; Male; S-Adenosylmethionine; Treatment Outcome | 2004 |
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
Topics: Adult; Benzophenones; Catechol O-Methyltransferase Inhibitors; Caudate Nucleus; Choline; Depressive Disorder, Major; Female; Frontal Lobe; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nitrophenols; Personality Inventory; Reference Values; S-Adenosylmethionine; Tolcapone; Treatment Outcome | 1999 |